Effects of Whey Protein Intervention on Body Composition and Muscle Function in the Elderly With Sacropenia

NCT ID: NCT02490410

Last Updated: 2015-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effects of different dose of whey protein intervention(in a daily dose of 0g, 10g, 20g) on lean body mass,body fat composition and muscular function state in the elderly with sacropenia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

whey protein

2 x 10g whey protein per day orally for 6 months

Group Type EXPERIMENTAL

protein supplement

Intervention Type DIETARY_SUPPLEMENT

whey protein+soy protein

10g whey protein + 10g soy protein per day orally for 6 months

Group Type OTHER

protein supplement

Intervention Type DIETARY_SUPPLEMENT

soy protein

2 x 10g soy protein per day orally for 6 months

Group Type OTHER

protein supplement

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

protein supplement

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People aged over 65 years.
* Usual gait speed less than 0.8m/s.
* Willing to participate in the study, consume the test product and perform all measurements.

Exclusion Criteria

* nervous system disease.
* Other diseases with movement disorder such as stroke,fracture,arthritis.
* people who unconsciousness and can not complete questionnaire
* long-term regular use of protein and antioxidant.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Huilian Zhu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Huilian Zhu

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhu Hui lian, professor

Role: CONTACT

+86 20 87331811

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CNS-YILI2014-034

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.